Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretreated metastatic breast cancer patients. A multicenter phase II trial. (Q54005841)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretreated metastatic breast cancer patients. A multicenter phase II trial. |
scientific article |
Statements
Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretreated metastatic breast cancer patients. A multicenter phase II trial. (English)
Donadio M
Manzin E
Berruti A
Bottini A
Gorzegno G
Danese S
DeFabiani E
Sarobba MG
Lorusso V
Castiglione F
Moro G
Bumma C
Dogliotti L
1 May 2001
47
5
391-396